Clinical Trial Update: Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study [EARLY_Phase 1]

View source ↗

Summary

An early-phase immune checkpoint inhibitor drug–drug interaction study is described with not-yet-recruiting status, covering gastrointestinal neoplasms, genitou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Neoplasms
• Genitourinary Cancer
• Melanoma
• Sarcoma
• Thoracic Cancer

Drugs mentioned

• Immune Checkpoint Inhibitor (ICI) - DDI Study

Snippet

Sponsor: Indiana University | Conditions: Gastrointestinal Neoplasms, Genitourinary Cancer | EARLY_Phase 1 | Status: NOT_YET_RECRUITING